Research Article
SNORD15B and SNORA5C: Novel Diagnostic and Prognostic Biomarkers for Colorectal Cancer
Table 3
Cox regression analysis for SNORD15B and overall survival of CRC.
| Variables | HR | Univariate | | HR | Multivariate | | 95% CI | 95% CI |
| Sex (female vs. male) | 1.010 | 0.669–1.524 | 0.964 | — | — | — | Age (≤ 70 vs. > 70) | 1.808 | 1.188–2.753 | 0.006 | 2.003 | 1.232–3.255 | 0.005 | TNM stage (stage I/II vs. stage III/IV) | 3.613 | 2.280–5.726 | <0.001 | 4.767 | 2.661–8.540 | < 0.001 | Lymphatic invasion (negative vs. positive) | 2.256 | 1.449–3.513 | <0.001 | 0.848 | 0.462–1.557 | 0.595 | Venous invasion (negative vs. positive) | 2.376 | 1.505–3.751 | < 0.001 | 1.696 | 0.949–3.032 | 0.075 | History of colon polyps (negative vs. positive) | 0.768 | 0.447–1.321 | 0.340 | — | — | — | SNORD15B expression (low vs. high)# | 1.651 | 1.081–2.522 | 0.020 | 2.198 | 1.334–3.622 | 0.002 |
|
|
#Cutoff threshold of SNORD15B expression was median value in all patients in this cohort. . |